In the long run, Pulmonx Corp (LUNG) Stock makes the most sense financially and strategically
Wells Fargo lowered the price target for the Pulmonx Corp (NASDAQ:LUNG) stock from “an Overweight” to “an Equal weight”. The rating was released on February 23, 2024, according to finviz. The research report from Wells Fargo has upgraded the stock from Equal Weight to Overweight, with a price target set at $15. The stock was […]
The Underside Of Pulmonx Corp (LUNG) Stock Is A Little Uncertain
Wells Fargo lowered the price target for the Pulmonx Corp (NASDAQ:LUNG) stock from “an Overweight” to “an Equal weight”. The rating was released on February 23, 2024, according to finviz. The research report from Wells Fargo has upgraded the stock from Equal Weight to Overweight, with a price target set at $15. The stock was […]
Opportunities: Pulmonx Corp (LUNG) Stock in the Short-Term and the Long-Term
Wells Fargo lowered the price target for the Pulmonx Corp (NASDAQ:LUNG) stock from “an Overweight” to “an Equal weight”. The rating was released on February 23, 2024, according to finviz. The research report from Wells Fargo has upgraded the stock from Equal Weight to Overweight, with a price target set at $15. The stock was […]
Pulmonx Corp (LUNG) Stock Has More Upside Than Fundamentals Suggest
Wells Fargo lowered the price target for the Pulmonx Corp (NASDAQ:LUNG) stock from “an Overweight” to “an Equal weight”. The rating was released on February 23, 2024, according to finviz. The research report from Wells Fargo has upgraded the stock from Equal Weight to Overweight, with a price target set at $15. The stock was […]
What makes Pulmonx Corp (LUNG) Stock unique?
Wells Fargo lowered the price target for the Pulmonx Corp (NASDAQ:LUNG) stock from “an Overweight” to “an Equal weight”. The rating was released on February 23, 2024, according to finviz. The research report from Wells Fargo has upgraded the stock from Equal Weight to Overweight, with a price target set at $15. The stock was […]
Trading Pulmonx Corp (LUNG) Stock is a good strategy
Wells Fargo lowered the price target for the Pulmonx Corp (NASDAQ:LUNG) stock from “an Overweight” to “an Equal weight”. The rating was released on February 23, 2024, according to finviz. The research report from Wells Fargo has upgraded the stock from Equal Weight to Overweight, with a price target set at $15. The stock was […]
